Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Pardes Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 41 | 57 | +16 |
| Shares | 35.0M | 39.1M | +4.07M (+11.6%) |
| Value | $573.0M | $282.3M | −$290.7M (−50.7%) |
New holders (21)
Institutions that held Pardes Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 2,112,411 | $15.3M | 0.00% |
| Frazier Life Sciences Management, L.P. | 2,081,007 | $15.0M | 1.28% |
| Vanguard Group Inc | 985,974 | $7.12M | 0.00% |
| BlackRock Inc. | 343,787 | $2.48M | 0.00% |
| TCG Crossover Management, LLC | 229,100 | $1.65M | 0.66% |
| Geode Capital Management, LLC | 222,988 | $1.61M | 0.00% |
| Charles Schwab Investment Management Inc | 146,804 | $1.06M | 0.00% |
| Manufacturers Life Insurance Company, The | 82,075 | $612.9K | 0.00% |
| State Street Corp | 82,420 | $595.0K | 0.00% |
| Northern Trust Corp | 50,096 | $362.0K | 0.00% |
| ExodusPoint Capital Management, LP | 49,699 | $359.0K | 0.01% |
| Barclays PLC | 42,800 | $309.0K | 0.00% |
| Squarepoint Ops LLC | 22,832 | $165.0K | 0.00% |
| Bank of America Corp | 17,550 | $127.0K | 0.00% |
| Jane Street Group, LLC | 16,771 | $121.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 14,601 | $105.0K | 0.01% |
| Bank of New York Mellon Corp | 10,337 | $75.0K | 0.00% |
| Citigroup Inc | 2,831 | $20.0K | 0.00% |
| Morgan Stanley | 2,763 | $20.0K | 0.00% |
| Royal Bank of Canada | 1,823 | $13.0K | 0.00% |
| Ovata Capital Management Ltd | 500 | $4.00K | 0.00% |
Sold out (5)
Institutions that held Pardes Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Frazier Management LLC | 2,457,507 | $40.2M |
| JS Capital Management LLC | 1,000,000 | $16.4M |
| Citadel Advisors LLC | 300,000 | $4.91M |
| HRT Financial LP | 69,962 | $1.15M |
| Point72 Hong Kong Ltd | 34 | $1.00K |